Literature DB >> 28468581

A new insight on reciprocal relationship between microRNA expression and epigenetic modifications in human lung cancer.

Roghayeh Sheervalilou1,2,3, Sakine Shirvaliloo4, Sedigheh Fekri Aval2,3,5, Amir Mahdi Khamaneh1,2, Akbar Sharifi2, Khalil Ansarin2, Nosratollah Zarghami2,5.   

Abstract

Lung cancer stands among the leading causes of cancer-related death in the world. Although the molecular network implicated in lung cancer development is extensively revealed, the mortality rate is only slightly improved. MicroRNAs are small, endogenous single-stranded evolutionary conserved non-coding RNAs which involve in a wide variety of biological processes including cell growth, proliferation, metabolism, and differentiation. MicroRNAs, as novel biomarkers, have multiple functions in normal lung tissue development, and aberrant expression profiles of certain microRNAs could induce lung tumorigenesis. Similar to that of protein-coding genes, microRNA expression and function are regulated by multiple factors as well as the epigenetic network including DNA methylation and histone modification mechanisms. Furthermore, microRNAs can themselves regulate key enzymes which drive epigenetic modifications and have a pivotal effect on the cell biology. In this review, we will look into the regulatory loop linkage between microRNA expression and epigenetic modifications, and then, we will discuss the effects of epigenetics on the miRNome, as well as the role of epi-microRNAs in controlling the epigenome in human lung cancer. Better knowledge of reciprocal connection between microRNAs and epigenome will help to develop novel microRNA-orientated diagnostic, prognostic and therapeutic strategies related to human lung cancer in future.

Entities:  

Keywords:  Lung cancer; biomarker; epigenetic modifications; microRNA

Mesh:

Substances:

Year:  2017        PMID: 28468581     DOI: 10.1177/1010428317695032

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  6 in total

1.  Swimming training attenuates pancreatic apoptosis through miR-34a/Sirtu in1/P53 Axis in high-fat diet and Streptozotocin-induced Type-2 diabetic rats.

Authors:  Mohammad Reza Alipour; Roya Naderi; Alireza Alihemmati; Roghayeh Sheervalilou; Rafighe Ghiasi
Journal:  J Diabetes Metab Disord       Date:  2020-10-29

2.  Let-7d and miR-185 Impede Epithelial-Mesenchymal Transition by Downregulating Rab25 in Breast Cancer.

Authors:  Arman Shahabi; Behrooz Naghili; Khalil Ansarin; Maryam Montazeri; Mehdi Dadashpour; Nosratollah Zarghami
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

3.  miR-203 inhibits cell proliferation, invasion, and migration of non-small-cell lung cancer by downregulating RGS17.

Authors:  Yongbin Chi; Qinqin Jin; Xinghui Liu; Limin Xu; Xiaoxue He; Yan Shen; Qiang Zhou; Jue Zhang; Mingming Jin
Journal:  Cancer Sci       Date:  2017-10-12       Impact factor: 6.716

Review 4.  [A Review of Epigenetic Modifications Regulate MicroRNA Expression in Lung Cancer].

Authors:  Xilin Hu; Kaihua Tian
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-07-20

5.  Expression of miR-127, miR-154, and miR-183 in Medullary Thyroid Carcinoma Tumors.

Authors:  Mahsa Rahmani Samani; Marjan Zarif-Yeganeh; Atefeh Mehrabi; Amir Nader Emami Razavi; Sara Sheikholeslami; Mehdi Hedayati
Journal:  Iran J Public Health       Date:  2021-02       Impact factor: 1.429

6.  The association of polymorphisms in miRNAs with nonsmall cell lung cancer in a Han Chinese population.

Authors:  Chuanyin Li; Yu Zhang; Yingfu Li; Qianli Ma; Shuyuan Liu; Yueting Yao; Fang Tan; Li Shi; Yufeng Yao
Journal:  Cancer Manag Res       Date:  2018-04-10       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.